Recent HbA1C value-Between 6.4 to 7 - Page 3 of 3 Posts on Medivizor
Navigation Menu

Recent HbA1C value-Between 6.4 to 7 Posts on Medivizor

Can a sensor-augmented insulin pump decrease the incidence of hypoglycemia?

Can a sensor-augmented insulin pump decrease the incidence of hypoglycemia?

Posted by on Jun 23, 2014 in Diabetes mellitus | 0 comments

In a nutshell The authors compared the incidence rates of moderate and severe hypoglycemia in traditional insulin pump therapy and sensor-augmented pump therapy. Some background Hypoglycemia (dangerously low blood glucose levels) is a critical obstacle to care of patients with type 1 diabetes. Type 1 diabetes patients require insulin therapy to...

Read More

Intensive glycemic control and cardiovascular risk

Posted by on Nov 13, 2013 in Diabetes mellitus | 0 comments

In a nutshell This review explored whether strict glycemic control can reduce the risk of cardiovascular events among diabetic patients. Some background Hyperglycemia, or high blood glucose levels, can damage both large and small blood vessels. Damage to large blood vessels significantly elevates the risk for complications such as heart attacks or...

Read More

A comparison of the efficacy and safety of an oral versus an injectable treatment for patients with type 2 diabetes mellitus

A comparison of the efficacy and safety of an oral versus an injectable treatment for patients with type 2 diabetes mellitus

Posted by on Aug 1, 2013 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether an oral dose of sitagliptin was as effective as an injectable dose of liraglutide in patients with type 2 diabetes mellitus (T2DM) uncontrolled with metformin alone. Some background Patients with T2DM do not produce enough insulin (or are resistant to insulin) to break down the glucose they take in from...

Read More

A comparison between the effects of Sulfonylurea and Metformin on cardiovascular events in patients with type 2 Diabetes Mellitus

A comparison between the effects of Sulfonylurea and Metformin on cardiovascular events in patients with type 2 Diabetes Mellitus

Posted by on Feb 23, 2013 in Diabetes mellitus | 1 comment

In a nutshell The present study compared the effects of therapy with either Metformin or Sulfonylureas (Glyburide, Glipizide) on cardiovascular events (heart attack and stroke) or death in patients with type 2 diabetes mellitus (DM2). The main findings were that treatment with Sulfonylurea was associated with an increased risk of cardiovascular disease...

Read More

The effects of a drastic change in lifestyle on the reversibility of Type 2 Diabetes

Posted by on Feb 23, 2013 in Diabetes mellitus | 0 comments

In a nutshell The present study examined the effects of a long-term intensive weight-loss intervention (ILI) on type 2 diabetes mellitus (T2DM). ILI was associated with a greater probability of partial remission (fasting blood sugar <126 mg/dl) of diabetes, and a low prevalence of absolute remission (normal blood sugar levels).  Some...

Read More